SYNVISC
FDA premarket approval P940015/S013 · decided 2009-04-10
Approval details
- PMA number
- P940015
- Supplement
- S013
- Supplement type
- 135 Review Track For 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- SYNVISC
- Generic name
- Acid, hyaluronic, intraarticular
- Applicant
- Sanofi Genzyme Corp.
- Date received
- 2008-09-25
- Decision date
- 2009-04-10
- Days to decision
- 197 days
- Decision code
- APPR
- Product code
- MOZ
- Advisory committee
- Orthopedic
- Expedited review
- No
- Location
- Cambridge, MA
- Statement
- APPROVAL FOR THE RELOCATION OF MANUFACTURING PROCESSES WITHIN THE SAME FACILITY AND THE ADDITION OF AN ALTERNATE SYRINGE FILLING MACHINE.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.